ArticlePLoS pathogens2018

Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication.

Krystelle Nganou-Makamdop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.